This inventor holds 1 USPTO granted patent. Top assignee: Blueprint Medicines Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Michael Ross Palmer: Innovator in Protein Kinase A Inhibition
Introduction
Michael Ross Palmer is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit protein kinase A. His work has implications for various therapeutic applications.
Latest Patents
Michael Ross Palmer holds a patent for "Inhibitors of protein kinase A." This patent describes compounds of Formula (I) and pharmaceutically acceptable salts capable of inhibiting protein kinase A and its mutants. The patent also covers pharmaceutical compositions comprising these compounds, processes for making them, and methods of using the same. He has 1 patent to his name.
Career Highlights
Palmer is associated with Blueprint Medicines Corporation, where he continues to advance research in the field of targeted therapies. His work at the company focuses on developing innovative solutions for cancer treatment and other serious diseases.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Michael Ross Palmer's contributions to the field of protein kinase A inhibition highlight his role as an important inventor in biochemistry. His innovative work continues to pave the way for advancements in therapeutic applications.